[Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005342:Fibrinolysis / Q000187:drug effects*; D006496:Heparinoids / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010919:Placebos / Q000627:therapeutic use
D006496:Heparinoids; D010919:Placebos
Valutazione clinica di un farmaco fibrinolitico in un disegno sperimentale cross-over.